(XONE) Bondbloxx Bloomberg One - Ratings and Ratios
U.S. Treasury, Notes, Bonds
Description: XONE Bondbloxx Bloomberg One
The Bondbloxx Bloomberg One Year Target Duration US Treasury ETF (XONE) is designed to invest at least 80% of its assets in U.S. Treasury securities with an average duration of approximately one year, providing a relatively stable investment option for those seeking to manage interest rate risk.
By focusing on U.S. Treasury notes and bonds included in the Bloomberg US Treasury Index, XONE offers a non-diversified portfolio that is heavily reliant on the performance of these securities. This concentrated approach may appeal to investors seeking targeted exposure to the U.S. Treasury market.
With an Assets Under Management (AUM) of $641.06 million, XONE has established a significant presence in the ETF market. As a Short Government ETF, it is well-positioned to capitalize on fluctuations in the U.S. Treasury market, particularly in environments where interest rates are expected to change.
Analyzing the technical data, we observe that XONEs last price is $49.59, with its 20-day, 50-day, and 200-day Simple Moving Averages (SMA) indicating a generally stable trend. The Average True Range (ATR) of 0.03 represents a relatively low volatility, suggesting that the ETF is not subject to extreme price swings. Given the current 52-week high and low of $49.59 and $47.22, respectively, it is likely that XONE will continue to trade within this range unless there are significant changes in the U.S. Treasury market.
Forecasting future performance, we can expect XONE to remain relatively stable, with potential for slight growth given its current SMA trends. However, if interest rates rise, the funds short duration may help mitigate potential losses. Conversely, if interest rates fall, XONEs returns may be limited due to its focus on short-term U.S. Treasury securities. As the AUM continues to grow, it is likely that XONE will remain a viable option for investors seeking targeted exposure to the U.S. Treasury market.
Based on the fundamental and technical data, our forecast suggests that XONE will continue to trade around its current price, with a potential target price of $50.50 in the next 6-12 months, assuming stable interest rates and continued demand for U.S. Treasury securities.
Additional Sources for XONE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
XONE ETF Overview
Market Cap in USD | 621m |
Category | Short Government |
TER | 0.03% |
IPO / Inception | 2022-09-13 |
XONE ETF Ratings
Growth Rating | 61.3 |
Fundamental | - |
Dividend Rating | 62.2 |
Rel. Strength | 11 |
Analysts | - |
Fair Price Momentum | 50.38 USD |
Fair Price DCF | - |
XONE Dividends
Dividend Yield 12m | 4.37% |
Yield on Cost 5y | 4.88% |
Annual Growth 5y | 64.35% |
Payout Consistency | 100.0% |
Payout Ratio | % |
XONE Growth Ratios
Growth Correlation 3m | 95.7% |
Growth Correlation 12m | 99.5% |
Growth Correlation 5y | 99.9% |
CAGR 5y | 4.37% |
CAGR/Max DD 5y | 10.91 |
Sharpe Ratio 12m | 1.15 |
Alpha | 0.52 |
Beta | -0.011 |
Volatility | 0.66% |
Current Volume | 113.3k |
Average Volume 20d | 82.4k |
Stop Loss | 48 (-3%) |
As of July 17, 2025, the stock is trading at USD 49.49 with a total of 113,300 shares traded.
Over the past week, the price has changed by +0.06%, over one month by +0.33%, over three months by +0.78% and over the past year by +4.64%.
Yes. Based on ValueRay's Analyses, Bondbloxx Bloomberg One (NYSE ARCA:XONE) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 61.25 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XONE is around 50.38 USD . This means that XONE is currently overvalued and has a potential downside of 1.8%.
Bondbloxx Bloomberg One has no consensus analysts rating.
According to our own proprietary Forecast Model, XONE Bondbloxx Bloomberg One will be worth about 54.4 in July 2026. The stock is currently trading at 49.49. This means that the stock has a potential upside of +9.96%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 54.4 | 10% |